VIVXF News and Press, Avivagen From 06/07/21

Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen” or the “Corporation”),a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhance and support immune function, ther...

2Q21 Results. For the fiscal second quarter ended April 30th, Avivagen reported revenue of $159,614 and a net loss of $2.2 million, or a loss of $0.04 per share. This compares to revenue of $29,625 and a net loss of $1.4 million, or $0.03 per share, in the same period last year. We had forecas...

Ottawa, ON /Business Wire/ June 2, 2021/ Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune ...

Avivagen (VIVXF): FQ2 GAAP EPS of -C$0.04.Revenue of C$0.16M (+433.3% Y/Y)Press Release For further details see: Avivagen reports FQ2 results

Second Quarter Highlights: Record 64.5 tonne order for OxC-beta TM Livestock over 18 months New expansion efforts and customer wins in Central and South America Launch of first product for human health. Avivagen Inc. (TSXV:...

Agreement with CSA Animal Nutrition to be terminated effective immediately Avivagen to explore new sales and distributions opportunities to capitalize on significant market opportunity in the United States Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen&#...

Order signifies important growth in key production territories in Mexico Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human application...

New Order. Yesterday, Avivagen announced it entered into a contract for a four tonnes per month recurring order from Meyenberg International, the Company's consultant in Mexico. The contract, which has a term of 18 months, includes an order for 500 kilograms delivered April 30th and a commitme...

Largest purchase amount and longest duration purchase to-date Four tonne per month order secured Order follows five successful OxC-beta TM Livestock commercial trials conducted with various species over the past six months Avivagen Inc. (TSXV:VIV, OTC...

Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances food production and supports immune function, thereby supporting g...